Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.6450 (4.01%) ($7.6450 - $7.6450) on Tue. Jul. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.9% (three month average) | RSI | 63 | Latest Price | $7.6450(4.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(32%) BND(22%) VCIT(22%) SLV(21%) IBB(20%) | Factors Impacting BCRX price | BCRX will decline at least -1.45% in a week (0% probabilities). XLRE(-33%) XLP(-28%) XLI(-23%) DIA(-23%) SPLV(-22%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.45% (StdDev 2.9%) | Hourly BBV | 2.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.41(3.17%) | 10 Day Moving Average | $7.32(4.44%) | 20 Day Moving Average | $7.21(6.03%) | To recent high | -13.7% | To recent low | 10.2% | Market Cap | $1.349b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |